BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28730707)

  • 41. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
    Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
    Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.
    Majumder K; Arora N; Modi S; Chugh R; Nomura A; Giri B; Dawra R; Ramakrishnan S; Banerjee S; Saluja A; Dudeja V
    J Gastrointest Surg; 2016 Jan; 20(1):53-65; discussion 65. PubMed ID: 26582596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
    Greco SH; Tomkötter L; Vahle AK; Rokosh R; Avanzi A; Mahmood SK; Deutsch M; Alothman S; Alqunaibit D; Ochi A; Zambirinis C; Mohaimin T; Rendon M; Levie E; Pansari M; Torres-Hernandez A; Daley D; Barilla R; Pachter HL; Tippens D; Malik H; Boutajangout A; Wisniewski T; Miller G
    PLoS One; 2015; 10(7):e0132786. PubMed ID: 26172047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives.
    Cortez NE; Mackenzie GG
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
    Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
    Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
    Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
    Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies.
    de Latouliere L; Manni I; Iacobini C; Pugliese G; Grazi GL; Perri P; Cappello P; Novelli F; Menini S; Piaggio G
    Ann Anat; 2016 Sep; 207():2-8. PubMed ID: 26704357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia.
    Di Sebastiano KM; Yang L; Zbuk K; Wong RK; Chow T; Koff D; Moran GR; Mourtzakis M
    Br J Nutr; 2013 Jan; 109(2):302-12. PubMed ID: 23021109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic cancer cachexia: three dimensions of a complex syndrome.
    Kordes M; Larsson L; Engstrand L; Löhr JM
    Br J Cancer; 2021 May; 124(10):1623-1636. PubMed ID: 33742145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss.
    Sato K; Hikita H; Shigekawa M; Kato S; Sasaki Y; Shinkai K; Fukuoka M; Kudo S; Sato Y; Fukumoto K; Shirai K; Myojin Y; Sakane S; Murai K; Yoshioka T; Nishio A; Kodama T; Sakamori R; Tatsumi T; Takehara T
    Cancer Sci; 2022 Dec; 113(12):4311-4326. PubMed ID: 36074525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
    Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
    Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered exocrine function can drive adipose wasting in early pancreatic cancer.
    Danai LV; Babic A; Rosenthal MH; Dennstedt EA; Muir A; Lien EC; Mayers JR; Tai K; Lau AN; Jones-Sali P; Prado CM; Petersen GM; Takahashi N; Sugimoto M; Yeh JJ; Lopez N; Bardeesy N; Fernandez-Del Castillo C; Liss AS; Koong AC; Bui J; Yuan C; Welch MW; Brais LK; Kulke MH; Dennis C; Clish CB; Wolpin BM; Vander Heiden MG
    Nature; 2018 Jun; 558(7711):600-604. PubMed ID: 29925948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.
    Beatty GL; Winograd R; Evans RA; Long KB; Luque SL; Lee JW; Clendenin C; Gladney WL; Knoblock DM; Guirnalda PD; Vonderheide RH
    Gastroenterology; 2015 Jul; 149(1):201-10. PubMed ID: 25888329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells.
    Wang F; Liu H; Hu L; Liu Y; Duan Y; Cui R; Tian W
    BMC Cancer; 2018 Apr; 18(1):360. PubMed ID: 29609556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Orthotopic model of human pancreatic ductal adenocarcinoma and cancer cachexia in nude mice.
    Jones-Bolin S; Ruggeri B
    Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.3. PubMed ID: 21948162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
    Gresham G; Placencio-Hickok VR; Lauzon M; Nguyen T; Kim H; Mehta S; Paski S; Pandol SJ; Osipov A; Gong J; Jamil LH; Nissen N; Lo SK; Hendifar AE
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1959-1968. PubMed ID: 34609081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
    Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
    Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
    Keenan BP; Saenger Y; Kafrouni MI; Leubner A; Lauer P; Maitra A; Rucki AA; Gunderson AJ; Coussens LM; Brockstedt DG; Dubensky TW; Hassan R; Armstrong TD; Jaffee EM
    Gastroenterology; 2014 Jun; 146(7):1784-94.e6. PubMed ID: 24607504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.